| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/25/2009 | WO2009077500A2 Azolylmethyloxiranes, use thereof and agents containing the same |
| 06/25/2009 | WO2009076711A1 Enzymes and methods for degrading chlorinated s-triazines |
| 06/25/2009 | WO2008130619A3 A composition comprising an inhibitor of pde4 and/or pde7 |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163591 Use of sugar phosphates, sugar phosphate analogs, amino acids and/or amino acid analogs for modulating the glucolysis-enzyme complex, the malate asparate shuttle and/or the transaminases |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163543 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 06/25/2009 | US20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/25/2009 | US20090163473 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES |
| 06/25/2009 | US20090163460 Diagnostics and therapeutics for early-onset menopause |
| 06/25/2009 | US20090163457 Compositions and methods for delivering a biologically active agent |
| 06/25/2009 | US20090163434 miR-20 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 06/25/2009 | US20090163425 Peptide Inhibiting Angiotensin Converting Enzyme |
| 06/25/2009 | US20090162430 Gelatin Capsule With Extra Cap for Combined Therapies |
| 06/25/2009 | US20090162340 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 06/25/2009 | US20090162326 Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth |
| 06/25/2009 | US20090162294 Disposable inhaler |
| 06/25/2009 | US20090162284 Anti-igf-i receptor antibody |
| 06/25/2009 | DE102007063535A1 Pharmazeutische Zusammensetzung zur Prophylaxe und/oder symptomatischen Behandlung von zystischer Fibrose A pharmaceutical composition for prophylaxis and / or symptomatic treatment of cystic fibrosis |
| 06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
| 06/24/2009 | EP2072522A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 06/24/2009 | EP2072082A2 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent |
| 06/24/2009 | EP2072049A2 Solid valsartan pharmaceutical compositions |
| 06/24/2009 | EP2072047A1 Therapeutic agent for opthalmic disease |
| 06/24/2009 | EP1483247B1 Aryl substituted pyrimidines and the use thereof |
| 06/24/2009 | EP1385522B1 Combination comprising a signal transduction inhibitor and an epothilone derivative |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1324767B1 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | EP1224861B1 Test method relating to adipose cells and to obesity by using a human h-pgds overexpressing non-human animal |
| 06/24/2009 | EP1011733B1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 06/24/2009 | CN101466357A Direct cellular energy delivery system |
| 06/24/2009 | CN100503829C Interleukin-18 mutants, their production and use |
| 06/24/2009 | CN100503639C Recombinant tumor specific antibody and use thereof |
| 06/24/2009 | CN100503638C Protein tau |
| 06/24/2009 | CN100503611C New use of specific cyclolignans |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503605C Benzimidazole derivative and its use as AII receptor antagonist |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503589C Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
| 06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/24/2009 | CN100502874C Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 06/24/2009 | CN100502650C Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 06/23/2009 | USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide |
| 06/23/2009 | US7550609 Biological conjugates for tumor targeted treatment; novel taxanes having mercapto or disulfide groups; side effect reduction without compromising their cytotoxicity |
| 06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/23/2009 | US7550562 Having pathogenic activity that can induce pemphigus lesion; a peptide specifically recognized by the monoclonal antibody and useful as a therapeutic drug for pemphigus autoimmune disease; drug screening |
| 06/23/2009 | US7550507 2-(alpha-hydroxypentyl) benzoate and its preparation and use |
| 06/23/2009 | US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | US7550432 Recombinant fusion proteins to growth hormone and serum albumin |
| 06/23/2009 | US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents |
| 06/23/2009 | US7550159 For treatment of cancer and autoimmune diseases; kits |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2459483C Plaster for the treatment of dysfunctions and disorders of nail growth |
| 06/23/2009 | CA2459400C Plaster for the treatment of dysfunctions and disorders of nails |
| 06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |
| 06/23/2009 | CA2430967C Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/23/2009 | CA2373852C Oligosaccharide aldonic acids and their topical use |
| 06/23/2009 | CA2346643C Model and method for inhibiting angiogenesis using photodynamic therapy |
| 06/23/2009 | CA2319686C Use of 2-amino-6-trifluoromehthoxybenzothiazole for preventing or treating cerebellum dysfunction |
| 06/23/2009 | CA2163456C New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 06/18/2009 | WO2009076141A2 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 06/18/2009 | WO2009075826A1 Methods for increasing white blood cells |
| 06/18/2009 | WO2009075824A1 Methods for increasing endothelial progentior cells |
| 06/18/2009 | WO2009075822A1 Methods for inhibiting t helper cell differentiation |
| 06/18/2009 | WO2009075782A1 Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075344A1 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof |
| 06/18/2009 | WO2009075334A1 Uterine fibroid cell growth inhibitor, and prophylactic or therapeutic agent for uterine fibroid comprising the inhibitor |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009074518A1 Combinations of prolinamide p2x7 modulators with further therapeutic agents |
| 06/18/2009 | WO2009074004A1 A method for preparation of a health care wine of cordyceps |
| 06/18/2009 | WO2009010296A3 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 06/18/2009 | WO2008121348A3 Peripheral opioid receptor antagonists and uses thereof |
| 06/18/2009 | US20090156803 Condensed furan compounds |
| 06/18/2009 | US20090156794 Compositions and methods for activating genes of interest |
| 06/18/2009 | US20090156694 Long-chain polyunsaturated fatty acid oil and compositions and preparation process for the same |
| 06/18/2009 | US20090156686 Composition containing higher fatty acid derivative and foods and drinks |
| 06/18/2009 | US20090156641 Inhibition of cyclooxygenase-2 activity |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156630 Anti-tumour polycyclic carboxamides |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156598 Imidazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156566 Method of treating middle ear infections |
| 06/18/2009 | US20090156528 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |